| http://www.w3.org/ns/prov#value | - on the MedWatch website at www.fda.gov/medwatch.Immunosuppressant Drugs: Required Labeling Changes(posted 7/14/2009)The FDA is requiring the makers of certain immunosuppressant drugs to update their labeling to reflect that immunosuppressed patients are at increased risk for opportunistic infections, such as activation of latent viral infections, including BK virus-associated nephropathy.
|
